Liver Transplant

California Pacific's Liver Disease & Transplant Program opened in 1988 and we have performed more than 1,200 liver transplants since then. Presently, we see nearly 1,000 new liver disease patients and perform more than 50 transplants annually. Our outcomes reflect the excellence of our transplant hepatologists and surgeons who are at the forefront of both clinical research and surgical innovations.

We are committed to providing the highest quality of care and publicly reporting our transplant outcomes. The graphs below show two markers of transplant quality: patient survival and graft survival.

Total Waitlisted Liver Transplant Patients (as of January 20, 2010)*:

  • United States = 15,768

  • California = 3,398

  • CPMC = 454
*Source: Organ Procurement and Transplantation Network (OPTN)

Patient Survival  |  Graft Survival

Patient Survival


Liver Transplant: Patient Survival. Percentage of Patients Surviving at End of Period. 1 Month (Patients receiving transplant between 7/1/06 and 12/31/08) = 99.1% (CPMC - Observed), 96.0% (CPMC - Expected). 96.9% (United States). 1 Year (Patients receiving transplant between 7/1/06 and 12/31/08) = 88.6% (CPMC - Observed), 85.8% (CPMC - Expected). 88.6% (United States). 3 Years (Patients receiving transplant between 1/1/04 and 6/30/06) = 82.4% (CPMC - Observed), 73.3% (CPMC - Expected). 78.0% (United States). Source: Scientific Registry of Transplant Recipients

How does California Pacific's survival compare to what is expected for similar patients?

  • 1 Month = Not significantly different

  • 1 Year = Not significantly different

  • 3 Years = Statistically higher
Liver patient survival is calculated at the 1 month mark following transplant, the 1 year mark and the 3 year milestone. The graph above shows the patient survival rate of transplanted patients at each milestone at California Pacific, and also shows the survival rate seen in the United States.
  • The "observed" value is the patient survival rate for each milestone as experienced at California Pacific.

  • The "expected" value is calculated based on transplant patient and donor characteristics which take factors such as age and patient diagnosis into consideration. The expected patient survival rate is the patient survival rate we would expect to see based on our patient and donor population's characteristics. A "statistically higher" difference between observed and expected value shows an extremely high quality of patient care.

Back to top

Graft Survival


Liver Transplant: Graft Survival. Percentage of Patients Surviving at End of Period. 1 Month (Patients receiving transplant between 7/1/06 and 12/31/08) = 99.1% (CPMC - Observed), 94.4% (CPMC - Expected). 94.6% (United States). 1 Year (Patients receiving transplant between 7/1/06 and 12/31/08) = 88.8% (CPMC - Observed), 84.2% (CPMC - Expected). 84.8% (United States). 3 Years (Patients receiving transplant between 1/1/04 and 6/30/06) = 80.5% (CPMC - Observed), 74.0% (CPMC - Expected). 73.0% (United States). Source: Scientific Registry of Transplant Recipients

How does California Pacific's survival compare to what is expected for similar patients?

  • 1 Month = Statistically higher

  • 1 Year = Not significantly different

  • 3 Years = Not significantly different
Liver patient graft survival looks at whether the patient's transplanted organ is functioning at the above milestones.

Learn more about our Liver Transplant Program.

Back to top